Could nitric oxide be a mediator of action of oxytocin on myocardial injury in rats? (Biochemical, histological and immunohistochemical study)

General Physiology and Biophysics

Volumn 35, Issue 3, 2016, Pages 353-362

  Hussien, Noha I ^a   Mousa, Ayman M ^a,b  

^a BENHA UNIVERSITY   (Egypt)

^b QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Apoptosis; Atosiban; Isoprenaline; Myocardial injury; Nitric oxide; Oxytocin

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ATOSIBAN; CASPASE 3; CREATINE KINASE; HEART ENZYME; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; NITRIC OXIDE; OXYTOCIN; OXYTOCIN RECEPTOR;

ADULT; ALBINO RAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIAC MUSCLE CELL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GENERAL CONDITION DETERIORATION; HEART MUSCLE INJURY; IMMUNOHISTOCHEMISTRY; INTERSTITIUM; LIPID PEROXIDATION; MALE; MORTALITY RATE; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; DOSE RESPONSE; IMMUNOLOGY; MYOCARDIAL INFARCTION; PATHOLOGY; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MYOCARDIAL INFARCTION; NITRIC OXIDE; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OXYTOCIN; TREATMENT OUTCOME;

EID: 84974628199     PISSN: 02315882     EISSN: 13384325     Source Type: Journal    
DOI: 10.4149/gpb_2015049     Document Type: Article

References (41)

1. Alizadeh A. M., Faghihi M., Sadeghipour H. R., Mohammadghasemi F., Khori V. (2011): Role of endogenous oxytocin in cardiac ischemic preconditioning. Regul. Pept. 167, 86-90 http://dx.doi.org/10.1016/j.regpep.2010.11.004
2. Bae S., Siu P. M., Choudhury S., Ke Q., Choi J.H., Koh Y.Y. (2010): Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA. Am. J. Physiol. 299, 1374-1381 http://dx.doi.org/10.1152/ajpheart.00168.2010
3. Bancroft J. D., Layton C. (2013): The hematoxylins and eosin with Connective tissue and stains. In: Bancroft's Theory and Practice of Histological Techniques. (Eds. S. K. Suvarna, C. Layton and J. D. Bancroft), 7th ed., pp. 187-214, Churchill Livingstone/ Elsevier, Philadelphia http://dx.doi.org/10.1016/B978-0-7020-4226-3.00011-1
4. Biondi-Zoccai G. G. L., Abbate A., Vasaturo F. (2004): Increased apoptosis in remote non-infarcted myocardium in multivessel coronary disease. Int. J. Cardiol. 94, 105-110 http://dx.doi.org/10.1016/j.ijcard.2003.07.001
5. Bories P. N., Bories C. (1995): Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin. Chem. 41, 904-907
6. Buytaert E., Callewaert G., Vandenheede J. R., Agostinis P. (2006): Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum. Autophagy 2, 238-240 http://dx.doi.org/10.4161/auto.2730
7. Cai L., Guangwu W., Luping G., Youchun J., James Y. K. (2002): Hyperglycemia-induced apoptosis in mouse myocardium mitochondrial cytochrome c-mediated caspase-3 activation pathway. Diabetes 51, 1938-1948 http://dx.doi.org/10.2337/diabetes.51.6.1938
8. Faghihi M., Alizadeh A. M., Khori V., Latifpour M., Khodayari S. (2012): The role of nitric oxide, reactive oxygen species, and protein kinase C in oxytocin-induced cardioprotection in ischemic rat heart. Peptides 37, 314-319 http://dx.doi.org/10.1016/j.peptides.2012.08.001
9. Fariba H., Mahdieh F., Saleh Z. (2015): Role of atrial natriuretic peptide in oxytocin induced cardioprotection. Heart Lung Circ. 24, 86-93 http://dx.doi.org/10.1016/j.hlc.2014.05.023
10. Forstermann U., Closs E. I., Pollock J. S., Nakane M., Schwarz P., Gath I. (1994): Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions. Hypertension 23, 1121-1131 http://dx.doi.org/10.1161/01.HYP.23.6.1121
11. Frangogiannis N. G., Wayne-Smith C., Entman M. L. (2002): The inflammation response in myocardial infarction. Cardiovasc. Res. 53, 31-47 http://dx.doi.org/10.1016/S0008-6363(01)00434-5
12. Gaziano T. A., Bitton A., Anand S., Abrahams-Gessel S., Murphy A. (2010): Growing epidemic of coronary heart disease in low-and middle-income countries. Curr. Probl. Cardiol. 35, 72-115 http://dx.doi.org/10.1016/j.cpcardiol.2009.10.002
13. Gurgun C., Ildizli M., Yavuzgil O., Sin A., Apaydin A., Cinar C., Kultursay H. (2008): The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure. Int. J. Cardiol. 123, 102-107 http://dx.doi.org/10.1016/j.ijcard.2006.11.152
14. Gutkowska J., Jankowski M., Antunes-Rodrigues J. (2014): The role of oxytocin in cardiovascular regulation. Braz. J. Med. Biol. Res. 47, 206-214 http://dx.doi.org/10.1590/1414-431X20133309
15. Houshmand F., Faghihi M., Zahediasl S. (2009): Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats. Peptide 30, 2301-2308 http://dx.doi.org/10.1016/j.peptides.2009.09.010
16. Iwamoto K., Chein C., Kato L. (1987): Effect of urethane anesthesia and age on organ blood flow in rats measured by hydrogen gas clearance method. J. Pharmacobiodyn. 10, 280-284 http://dx.doi.org/10.1248/bpb1978.10.280
17. John L. W. (2005): Nitric oxide as a regulator of inflammatory processes. Mem. Inst. Oswaldo Cruz, Rio de Janeiro 100, 5-9
18. Francis J., Chu Y., Johnson A. K., Weiss R. M., Felder R. B. (2004): Acute myocardial infarction induces hypothalamic cytokine synthesis. Am. J. Physiol. Heart Circ. Physiol. 286, 2264-2271 http://dx.doi.org/10.1152/ajpheart.01072.2003
19. Kewalramani G., Puthanveetil P., Wang F., Kim M. S., Deppe S., Abrahani A., Luciani D. S., Johnson J. D., Rodrigues B. (2009): AMP-activated protein kinase confers protection against TNF-a induced cardiac cell death. Cardiovasc. Res. 84, 42-53 http://dx.doi.org/10.1093/cvr/cvp166
20. Khatua T. N., Padiya R., Karnewar S., Kuncha M., Agawane S. B., Kotamraju S., Banerjee S. K. (2012): Garlic provides protection to mice heart against isoproterenol-induced oxidative damage: role of nitric oxide. Nitric Oxide 27, 9-17 http://dx.doi.org/10.1016/j.niox.2012.03.004
21. King J. (1965): The dehydrogenases or oxi-reductase-Lactate dehydrogenase. In: Practical Clinical Enzymology. van Nostrand, London
22. Lee Y., Gustafsson A. B. (2009): Role of apoptosis in cardiovascular disease. Apoptosis 14, 536-548 http://dx.doi.org/10.1007/s10495-008-0302-x
23. Madhesh M., Ramalingam R., Vaiyapuri M. (2011): Cardioprotective effect offenugreek on isoproterenol-induced myocardial infarction in rats. Indian J. Pharmacol. 43, 516-519 http://dx.doi.org/10.4103/0253-7613.84957
24. Mahammad R. S., Kodidhela L. D. (2013): Origination and development of isoproterenol-induced myocardial infarction in male Wistar rats. Int. Res. J. Pharm. 5, 26-36
25. Menaouar A., Florian M., Wang D., Danalache B., Jankowski M. (2014): Anti-hypertrophic effects of oxytocin in rat ventricular myocytes. Int. J. Cardiol. 175, 38-49 http://dx.doi.org/10.1016/j.ijcard.2014.04.174
26. Moghimian M., Faghihi M., Karimian S. M., Imani A. (2012): The effect of acute stress exposure on ischemia and reperfusion injury in rat heart: Role of oxytocin. Stress 15, 385-392 http://dx.doi.org/10.3109/10253890.2011.630436
27. Ndiaye K., Poole D. H., Pate J. L. (2008): Expression and regulation of functional oxytocin receptors in bovine T lymphocytes. Biol. Reprod. 78, 786-793 http://dx.doi.org/10.1095/biolreprod.107.065938
28. Offerman E. L., Modell C. B., Dormandy T. L., Stocks J. B. (1972): The susceptibility to autoxidation of human red cell lipids in health and disease. J. Haematol. 23, 713-724 http://dx.doi.org/10.1111/j.1365-2141.1972.tb03486.x
29. Okinaka S., Kumagai H., Ebashi S., Sugita H., Momoi H., Toyokura Y., Fujie Y. (1961): Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases. Arch. Neurol. 4, 520-525 http://dx.doi.org/10.1001/archneur.1961.00450110050006
30. Ovize M., Baxter G. F., Di L. F., Ferdinandy P., Garcia-Dorado D., Hausenloy D. J. (2010): Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc. Res. 87, 406-423 http://dx.doi.org/10.1093/cvr/cvq129
31. Paglia D. E., Valentine W. E. (1967): Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase J. Lab. Clin. Med. 70, 158-169
32. Palacios Callender M., Quintero M., Hollis V. S., Springett R. J., Moncada S. (2004): Endogenous NO regulates superoxide production at low oxygen concentrations by modifying the redox state of cytochrome c oxidase. Proc. Natl. Acad. Sci. USA 101, 7630-7635 http://dx.doi.org/10.1073/pnas.0401723101
33. Paul-Clark M. J., Roviezzo F., Flower R. J., Cirino G., Soldato P. D., Adcock I. M., Perretti M. (2003): Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands. J. Immunol. 171, 3245-3252 http://dx.doi.org/10.4049/jimmunol.171.6.3245
34. Rajadurai M., Prince P. S. (2006): Preventive effect of naringin on lipids, lipoproteins and lipid metabolic enzymes in isoproterenol-induced myocardial infarction in Wistar rats. J. Biochem. Mol. Toxicol. 20, 191-197 http://dx.doi.org/10.1002/jbt.20136
35. Russell R. R., Li J., Coven D. L., Pypaert M., Zechner C., Palmeri M., Giordano F. J., Mu J., Birnbaum M. J., Young L. H. (2004): AMP activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J. Clin. Invest. 114, 495-503 http://dx.doi.org/10.1172/JCI19297
36. Szeto A., Nation D. A., Mendez A. J., Dominguez-Bendala J., Brooks L. G., Schneiderman N., McCabe P. M. (2008): Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am. J. Physiol. Endocrinol. Metab. 295, 1495-1501 http://dx.doi.org/10.1152/ajpendo.90718.2008
37. Szeto A., Rossetti M. A., Mendez A. J., Noller C. M., Herderick E. E. (2013): Oxytocin administration attenuates atherosclerosis and inflammation in Watanabe Heritable Hyperlipidemic rabbits. Psychoneuroendocrinology 38, 685-693 http://dx.doi.org/10.1016/j.psyneuen.2012.08.009
38. Tawfik M. K., Ghattas M. H., Abo-Elmatty D. M., Abdel-Aziz N. A. (2010): Atorvastatin restores the balance between proinflammatory and anti-inflammatory mediators in rats with acute myocardial infarction. Eur. Rev. Med. Pharmacol. Sci.14, 499-506
39. Upaganlawar A., Gandhi H., Balaraman R. (2010): Effect of vitamin E alone and in combination with lycopene on biochemical and histopathological alterations in isoproterenol-induced myocardial infarction in rats. J. Pharmacol. Pharmacother. 1, 24-31 http://dx.doi.org/10.4103/0976-500X.64532
40. Whelan R. S., Kaplinskiy V., Kitsis R. N. (2010): Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev. Physiol. 72, 19-44 http://dx.doi.org/10.1146/annurev.physiol.010908.163111
41. Wsol A., Cudnoch-Jedrzejewska A., Szczepanska-Sadowska E., Kowalewski S., Puchalska L. (2008): Oxytocin in the cardiovascular responses to stress. J. Physiol. Pharmacol. 8, 123-127